{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Showing 1 - 7 of 7 results
Status:
Investigational
Source:
INN:pemlimogene merolisbac [INN]
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
INN:axalimogene filolisbac [INN]
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT00327652: Phase 1 Interventional Completed Neoplasm Metastasis
(2006)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT03006302: Phase 2 Interventional Active, not recruiting Metastatic Pancreatic Adenocarcinoma
(2018)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Designated
Source:
FDA ORPHAN DRUG:386212
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE